Meet The Team How-Tos Our Supporters How to Participate in Precision Panc Membership Meeting Minutes Remit of Steering Committee Patient Stories Documents Working with the NHS Patient Public Engagement Meetings Governance News Clinicians Area Clinical Trials What is precision medicine? Information and Support What is Pancreatic Cancer? Current Research Our Researchers Privacy Policy Patients and Carers Contact Us About us Home
Survey on the impact of COVID-19 pandemic on pancreatic cancer research Precision-Panc in the Press Precision-Panc / PRIMUS 002 Opens a new site Precision-Panc Re-opens to Recruitment Information on COVID-19 and Pancreatic Cancer from PCUK Precision-Panc and PRIMUS studies suspended to recruitment Precision-Panc Recruits Patient 300 Paul Taylor tells us about his Precision-Panc experience Precision-Panc help raise funds for Pancreatic Cancer Scotland Precision-Panc Recruits Patient 250 Marking World Pancreatic Cancer Day Precision-Panc working with myTomorrows Precision-Panc Roundtable Final Report New Glasgow Cancer Assays by GPOL and Agilent Technologies Precision-Panc opens site 25! Precision-Panc Summer Newsletter Precision-Panc Recruits Patient 200! Precision-Panc Brochure Royal Bournemouth Hospital Opens Finding the right treatment for the patient CRUK animate the Precision-Panc platform CRUK / Precision-Panc Video Professor Biankin receives the Order of Australia in Queen’s Birthday Honours Precision-Panc opens its 20th Site Precision Panc Spring Newsletter Precision-Panc Opens Site 19 Recent Media Pieces Regarding 100 Patient Milestone Site 17 opens for Precision-Panc PRIMUS 002 opens Informing the Future of Genomic Medicine in Scotland Report is Published St James’s University Hospital Opens Precision-Panc Opens its 15th site Glasgow Experts Lead UK Pancreatic Cancer Research 11th site opens to PRECISION-Panc Scotsman Conferences Blogspot November is Pancreatic Cancer Awareness Month First Precision-Panc Trial Opens In Glasgow Cancer Research UK Investment Landscape of pancreatic neuroendocrine cancer Whole Genome Sequencing from EUS biopsies Upcoming Pancreas 2016 Conference Scottish Genome Partnership Announced Identification of four Pancreatic Cancer subtypes offers new treatment insight into the disease First Minister announces £4m ‘Precision Medicine Ecosystem’
Home | Team Members | Susie Cooke

Head of Medical Genomics

Glasgow Precision Oncology Laboratory

Susie Cooke

Head of Medical Genomics

Dr Susie Cooke and her team have recently developed the Glasgow Cancer Tests – a suite of assays for common adult solid cancers that identifies the biologically and clinically relevant features that are driving each patient’s cancer.

Dr Susie Cooke is a cancer genomics and bioinformatics expert, bridging the gap between biological and clinical questions about cancer and the computational methods needed to solve them – and then working to ensure the successful application of the resulting methods and technologies in the healthcare system. Dr Cooke has extensive knowledge of cancer genomics and applies this in work with industry, academic research and clinical/drug trials.

At GPOL she manages multidisciplinary teams across ‘wet’ laboratories that test and analyse DNA, or other biological materials, and ‘dry’ laboratories, where computers or computer-generated models are used for analysis.

Following a PhD in 2007 on cancer genomics that focused on alterations of chromosome 8 in breast cancer, Dr Cooke became a research fellow at Cancer Research UK’s Cambridge Institute, where she began doing experiments using next-generation sequencing, a technology that generates millions (or even billions) of data points for each sample. The tools hadn’t yet been invented to analyse this type and scale of data, so Dr Cooke started working with bioinformaticians, who wrote computer code to process the data.

In 2011, Dr Cooke took up a research fellowship in the Cancer Genome Project at the Wellcome Sanger Institute, where she continued to bridge between the data – how it’s generated and what properties it has from a biological sense – and what that means in terms of what a computer needs to do to it. She also began transitioning herself into bioinformatics.

Dr Cooke explained: ‘Next-generation sequencing technologies for studying genomics came to market during my PhD and first post-doc, so my career has grown up with them. They’ve really changed a lot in that time (as anyone who remembers nebulising DNA, size selecting on gels and getting excited about 30bp reads on a Genome Analayzer will confirm!). By understanding how things are done in the lab from my past experience, and how the technology has evolved, I know how to make the most of the data and a lot of the pitfalls to avoid – a classic case of being in the right place at the right time!’

In 2014 Dr Cooke joined the Sanger Institute cancer genomics startup, 14M Genomics, where she worked creating cancer tests and analysis pipelines and partnering with people doing drug trials to deliver genomic cancer test reports for patients.

In 2016, Professor Andrew Biankin established the Glasgow Precision Oncology Laboratory at the University of Glasgow to support his work in pancreatic and other cancers, with Dr Cooke as Head of Medical Genomics, managing a team in the next-generation sequencing and bioinformatics facility and delivering sequencing, analysis and interpretation of cancer genomic data for national projects, such as the Scottish Genomes Partnership, and drug trials, including the UK-wide Precision-Panc trials for patients with pancreatic cancer, as well as collaborating with local academic investigators.

‘We’re working in that gap after translational research, where you’re taking research that has potential to be translated into the healthcare system, and actually translating it’, said Dr Cooke. ‘Essentially, it’s solving a gigantic and complex problem to deliver a product that’s not just a good product, but the right product. It’s never going to be perfect, but the right compromises have to be made in the right places. It has to do the best job it can do for the purpose for which it’s intended, whilst still being practical, with the extra pressure that people’s lives are on the other end of it.’

Dr Cooke has authored the Cancer and Bioinformatics chapters of the Scottish Science Advisory Council’s Report on ‘Informing the Future of Genomic Medicine in Scotland’, and co-authored the Scottish Genomes Partnership’s response to the House of Commons Science and Technology Committee Inquiry on Genomics and Genome Editing in the NHS. She led GPOL’s contribution to the National Institute for Biological Standards and Control’s preparation of the proposed WHO 1st International Standards for Cancer Genomes and is chair of the ACGS Driver Working Group, drafting national best practice guidelines.

© 2020 Precision Panc
Web design by Creatomatic
This site uses cookies.
Read our privacy policy

This site uses cookies for marketing, personalisation, and analysis purposes. You can opt out of this at any time or view our full privacy policy for more information.